HomeDVAX • NASDAQ
add
Dynavax Technologies Corp
Previous close
$11.43
Day range
$11.34 - $11.49
Year range
$9.20 - $14.63
Market cap
1.34B USD
Avg Volume
1.70M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 94.88M | 17.67% |
Operating expense | 38.50M | -7.28% |
Net income | 26.93M | 53.05% |
Net profit margin | 28.38 | 30.06% |
Earnings per share | 0.21 | 75.00% |
EBITDA | 24.79M | 84.00% |
Effective tax rate | 5.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 647.82M | -15.21% |
Total assets | 946.51M | -10.87% |
Total liabilities | 412.37M | 8.36% |
Total equity | 534.14M | — |
Shares outstanding | 117.42M | — |
Price to book | 2.51 | — |
Return on assets | 6.30% | — |
Return on capital | 7.31% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 26.93M | 53.05% |
Cash from operations | 33.83M | 73.78% |
Cash from investing | 27.32M | 276.68% |
Cash from financing | -61.00K | -102.46% |
Net change in cash | 61.15M | 793.82% |
Free cash flow | 19.88M | 70.44% |
About
CEO
Founded
1996
Headquarters
Website
Employees
405
